Why IMU is a multi multi bagger, page-24991

Fibber, Did you pick up the following paragraph from @melburnian recent post?

“Our physicians who specialize in hematologic malignancy are now generating excitement regarding the use of bispecifics instead of CAR T cells in select patients. I am curious whether there is any role down the road for bispecifics for this model.”

Once again IMU demonstrates they are all over this cancer therapy space. Oasis is using BLINCYTO.

@Fact Finder your post was well worth highlighting and reposting. It’s probably hard for people to understand just how much preparation has gone into designing these trials and developing ONCARLYTICS.
It certainly appears most people either didn’t read Melburnian’d post or didn’t comprehend the importance of the information it contained.

https://hotcopper.com.au/posts/74503303/single

@Outlander2,

another great contribution from yourself. It’s worth reflecting on where we started and where we are now in our journey to cure cancer. In November 2019 IMU hit .066 on news of acquiring CF33 from Yuman Fong and the COH. Now after hundreds of millions of dollars, 5 years of painstakingly diligent work by many experts, we are less than 6 months from early data regarding ONCATLYTICS and BLINCYTO combined therapy.

And we closed at .054 , that’s 20% lower than 2019 before we started. It’s amazes me that the market and so many posters don’t see the value proposition here.

It’s not as if it’s a major binary event coming up. There is good data from BLINCYTO trials. It works. Good data from Animal studies. On all components of the combo trial. ONCARLYTICS has been in mono trials in humans for 9 months with no reported adverse events.

And even more startling we have the CEO who is a world leader in cancer studies stating quite clearly on video for the world to watch that she is seeing DATA from these OPEN label trials unlike anything she’s ever seen. That CF33 is unique, nothing like it anywhere in the world. Remembering she is an expert in this very specific field.

If she wrote those statements on a piece of paper and faxed it over to the ASX, the shareprice would rocket upwards. But it was on video, because she needs the results verified, so the market dumps their shares.

We will look back on this some day and it will be obvious to all just how ludicrous this situation is. Similar to COVID response that saw hysteria and stupidity on a Global Scale!